According to Intent Market Research, the PARP Inhibitor Biomarkers Market is expected to grow from USD 1.2 Billion in 2024-e at a CAGR of 21.8% to touch USD 3.9 Billion by 2030. The PARP Inhibitor Biomarkers Market is dominated by key players such as, AstraZeneca, Merck & Co., Pfizer, Roche, GlaxoSm... Read More
According to Intent Market Research, the Paroxysmal Nocturnal Hemoglobinuria Therapeutics Market is expected to grow from USD 6.3 Billion in 2024-e at a CAGR of 8.6% to touch USD 10.3 Billion by 2030. The Paroxysmal Nocturnal Hemoglobinuria Therapeutics Market is dominated by key players such as, Al... Read More
According to Intent Market Research, the Parkinson's Disease Therapeutics Market is expected to grow from USD 4.5 Billion in 2024-e at a CAGR of 4.4% to touch USD 5.9 Billion by 2030. The Parkinson's Disease Therapeutics Market is dominated by key players such as, AbbVie Inc., Pfizer Inc., Novartis ... Read More
According to Intent Market Research, the Pancreatic Cancer Diagnostics Market is expected to grow from USD 2.6 Billion in 2024-e at a CAGR of 6.0% to touch USD 3.7 Billion by 2030. The Pancreatic Cancer Diagnostics Market is dominated by key players such as, F. Hoffmann-La Roche AG, Myriad Genetics,... Read More
According to Intent Market Research, the Treatment Planning Systems and Advanced Image Processing Market is expected to grow from USD 1.9 Billion in 2024-e at a CAGR of 14.0% to touch USD 4.6 Billion by 2030. The Treatment Planning Systems and Advanced Image Processing Market is dominated by key pla... Read More
According to Intent Market Research, the Rare Diseases Treatment Market is expected to grow from USD 211.8 billion in 2024-e at a CAGR of 7.2% to touch USD 321.5 billion by 2030. The Rare Diseases Treatment Market is dominated by key players such as, Novartis, Pfizer Inc., GlaxoSmithKline, Bristol-M... Read More
According to Intent Market Research, the Prescription Hair Loss Treatment Drugs Market is expected to grow from USD 3.6 billion in 2024-e at a CAGR of 8.3% to touch USD 5.8 billion by 2030. The Prescription Hair Loss Treatment Drugs Market is dominated by key players such as, Merck & Co., Inc., Pfiz... Read More
According to Intent Market Research, the Prenatal and Newborn Genetic Testing Market is expected to grow from USD 9.7 billion in 2024-e at a CAGR of 8.5% to touch USD 15.8 billion by 2030. The Prenatal and Newborn Genetic Testing Market is dominated by key players such as, Thermo Fisher Scientific I... Read More
According to Intent Market Research, the Premature Ejaculation Treatment Market is expected to grow from USD 2.7 billion in 2024-e at a CAGR of 7.0% to touch USD 4.1 billion by 2030. The Premature Ejaculation Treatment Market is dominated by key players such as, Johnson & Johnson, Eli Lilly and Co.,... Read More
According to Intent Market Research, the Preimplantation Genetic Diagnosis Market is expected to grow from USD 4.8 billion in 2024-e at a CAGR of 9.6% to touch USD 8.3 billion by 2030. The Preimplantation Genetic Diagnosis Market is dominated by key players such as, Thermo Fisher Scientific, Illumin... Read More